The largest database of trusted experimental protocols

34 protocols using normal saline

1

Isolation of Salivary Polymorphonuclear Neutrophils

Check if the same lab product or an alternative is used in the 5 most similar protocols
Patients were instructed to perform five 30 s oral rinses separated by one minute with 3 mL of sterile 0.9% normal saline (Baxter). The oral rinse samples were deposited into a 50 mL conical tube (Becton Dickinson) and immediately subjected to sequential filtration utilizing a sterile 40 μm nylon mesh sterile cell strainer (Fisher Scientific) followed by 20 μm and 11 μm nylon net filters (Millipore). The filtrate was centrifuged for 10 min at 1500 RCF and the cell pellet was resuspended in 1 mL of sterile PBS-/-. Recovered salivary PMNs were quantified using a Z2 Cell and Particle Counter (Beckman Coulter) and demonstrated 95% cell viability and 98% purity as assessed by a trypan blue exclusion test and Kwik-Diff staining (Thermo Fisher Scientific), respectively.
+ Open protocol
+ Expand
2

Preparation of Talc Slurry for Visualization

Check if the same lab product or an alternative is used in the 5 most similar protocols
50 ml of a sterile 0.9% normal saline (Baxter Healthcare Ltd, Norfolk, United Kingdom) was injected via a 50 ml syringe (Terumo Europe N.V., Leuven, Belgium) into a vial containing 4g of sterile talc powder (STERITALC® F4, Novatech SA, La Ciotat, France). The contents of the vial were shaken to ensure all of the talc was suspended in the normal saline, and was then withdrawn into the syringe. For aiding visualisation in mechanical and distribution testing, 2 ml of green dye (water, tartrazine E102, green S E142, acetic acid, Goodalls Spices Green Colouring) was added to the talc slurry.
+ Open protocol
+ Expand
3

Lipid-Based Nanoparticle Formulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
All of the lipids used in this study were either from Avanti Polar Lipids (Alabaster, AL) or Lipoid (Ludwigshafen, Germany). PEG6000 monostearate was from Stepan Kessco (Northfield IL). Decafluorobutane gas was from F2 Chemicals (Lea, Lancashire, UK). Salts and buffer components were from Sigma (St. Louis, MO) unless stated otherwise. Normal saline was from Baxter (Chicago, IL).
+ Open protocol
+ Expand
4

Bovine FITC-Albumin and Rhodamine 6G Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Normal saline (0.9%, NS) was purchased from Baxter Healthcare Corporation (Deerfield, IL), ketamine from Hospira (Lake Forest, IL), xylazine from Akorn (Decatur, IL) and acepromazine from Boehringer Ingelheim (St. Joseph, MO). Bovine fluorescein isothiocyanate (FITC)-labeled albumin and 0.3% rhodamine 6G were purchased from Sigma-Aldrich (St. Louis, MO). 2-O, 3-O desulfated heparin (ODSH) was supplied from Cantex Pharmaceuticals (Weston, FL) and per the company is manufactured as a pharmaceutical grade compound under Good Manufacturing Practices.
+ Open protocol
+ Expand
5

Investigating Urotensin II and Adrenergic Mechanisms

Check if the same lab product or an alternative is used in the 5 most similar protocols
The drugs used were Human Urotensin II (Servier, Australia), L-phenylephrine HCl (Sigma Company, Australia), and clonidine HCl (Boehringer Ingelheim Pty Ltd, Australia). The doses of drugs were expressed in μg of the base. Drugs administered into the lateral ventricle or fourth ventricle were dissolved in Ringer's (Baxter, Old Toongabbie, NSW, Australia) solution while drugs given i.v. were dissolved in normal saline (Baxter, Old Toongabbie, NSW, Australia).
+ Open protocol
+ Expand
6

Establishment of Animal Mechanical Ventilation Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
An animal mechanical ventilation model was established and modified as previously described [10 (link)]. In detail, animals were anesthetized with sodium pentobarbital (40 mg/kg body weight, IP). After anesthesia, animals were placed on a recirculating heating blanket and fixed. Then, animals were tracheostomized and connected to a volume-driven small animal ventilator (VentElite, Harvard Apparatus; Cambridge, MA, USA). The tidal volume (TV) was set at 5 mL/kg body weight, and the respiratory rate (RR) was set at 55 to 60 breaths/min. Breathing air was humidified and enriched with oxygen. To avoid ventilator-induced systemic hypoxia, the ventilator parameters and oxygen flow were adjusted to maintain PaO2 between 80 and 100 mmHg and PaCO2 between 35 and 45 mmHg during the entire study. The values of PaO2 and PaCO2 were determined through arterial blood gas analysis, which was performed every 2 hours during the study. Blood pressure (BP) and heart rate (HR) were monitored at the tail using tail cuff plethysmography (BP-2010 Series Blood Pressure Meter, Softron, Japan). The right jugular vein was cannulated for continuous infusion of normal saline (Baxter, Deerfield, IL) at a rate of 1 mL/kg−1/h−1 and pentobarbital sodium (10 mg/kg−1/h−1) using an electric pump. Body temperature was maintained at 37°C during the experiment by external warming with a homeothermic blanket system.
+ Open protocol
+ Expand
7

Burn Wound Depth Assessment Using Fluorescent Dyes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Clinical tissue samples were obtained through the University of Wisconsin Hospital as described previously.3 (link) This study was approved by the University of Wisconsin Human Subjects Committee Institutional Review Board in compliance with the 1975 Declaration of Helsinki. Briefly, samples were obtained from patients with indeterminate depth burn injury at the time of surgery, 6–13 days after burn injury following a period of observation to assess healing trajectory. Intraoperatively, burn wound depth was determined by the burn surgeon using visual assessment prior to and during excision.3 (link) Normal skin tissue used as a control was obtained from non-burn related elective reconstructive surgery. Control non-burned and burned tissue samples were stored for up to 1 hour in normal saline (Baxter) prior to further processing. A 6-mm biopsy punch was taken from the skin samples and 100 μL of 100 μM Cy5-CMP or 100 μL of 100 μM Cy5-CI was applied directly onto the superficial side of the biopsy, fully submerged in dye solution, and incubated in a petri dish covered with aluminum foil at room temperature for 1 hour. The samples (n=6 burn pairs) were washed three times in rapid succession with 1× PBS (Sigma) prior to imaging and kept covered in 1× PBS. Images were collected from both superficial and deep surfaces of the biopsies immediately following rinsing.
+ Open protocol
+ Expand
8

Spinal Cord Injury Mouse Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were anesthetized with Ketamine (80 mg/kg; Vedco, St. Joseph, MO) and Xylazine (10 mg/kg; Akorn Inc., Decatur, IL) that was administered via intraperitoneal (ip) injection. Following a laminectomy at thoracic level 8 (T8), a severe contusion injury (70 kilodyne force) was induced using the Infinite Horizon Impactor (Precision Systems and Instrumentation, Lexington, KY). Uninjured mice were anesthetized, received superficial skin incisions, and received wound clips to ensure blinded evaluations. Since a laminectomy does not induce major inflammatory changes in the SC (Supplementary Fig. 9), a surgical control was not included in the current studies. Immediately postoperatively, all mice received subcutaneous injections of Lactated Ringers solution (1 ml; Baxter, Deerfield, IL), Baytril (0.02 ml; Bayer, Kansas City, KS), and Buprenorphine (0.05 ml; Hospira, Lake Forest, IL). Antibiotics, analgesics, and 1 ml of normal saline (Baxter) were administered to mice twice daily for 7 days thereafter. Bladders were manually expressed twice per day. On day 1 post-injury (pi), hind limb locomotor function was assessed with the Basso Mouse Scale (BMS)64 (link) to confirm that all mice received an injury of equivalent severity (BMS score ≤ 2), and that each uninjured mouse exhibited normal baseline stepping and coordination (BMS score = 9).
+ Open protocol
+ Expand
9

GLP-1 Encapsulation in Stealth Solid Micelles

Check if the same lab product or an alternative is used in the 5 most similar protocols
GLP-1 in SSM was prepared as described previously by us.18 (link) Briefly, SSM was prepared by mixing 5 mM 1,2-distearyl-snglycero-3-phosphatidylethanolamine-N-[methoxy(polyethyleneglycol)-2000 (DSPE-PEG2000, Ludwigshafen, Germany) in normal saline (Baxter, IL, USA) by vortexing for 2 minutes followed by incubation of the dispersion at 25 °C for 1 hour in the dark. Human GLP-1 (Protein Research Laboratory, University of Illinois at Chicago, Chicago, IL) in normal saline was added to SSM at a constant molar ratio of GLP-1:SSM (1:30) at all times (final concentration 15 nmol/100 µl), and the dispersion was further incubated at 25 °C for 2 hours in the dark. Particle size analysis of aqueous native GLP-1, SSM and GLP-1-SSM was conducted by dynamic light scattering (Agilent 7030 NICOMP DLS, Agilent Technologies, Santa Clara, CA). The size of SSM and GLP-1-SSM was ~13 nm as a single peak while aqueous GLP-1 was heterogenous with dominating peak at ~1700 nm in diameter as previously shown by us.18 (link)
+ Open protocol
+ Expand
10

Efficacy of APP96-110 Peptide on SCI

Check if the same lab product or an alternative is used in the 5 most similar protocols
Custom APP96-110 (active) and mAPP96-110 (mutant; with reduced heparin binding ability (Corrigan et al., 2014)) peptides were produced by Auspep Pty Ltd (Tullamarine, VIC, Australia) according to the sequences; APP96-110: AC-N W C K R G R K Q C K T H P H-NH2; mAPP96-110: AC-N W C N Q G G K Q C K T H P H-NH2). The APP96-110 peptide contained a disulphide bridge between cysteines 98 and 105, important for efficacy (Small et al., 1994; Corrigan et al., 2014). For animals that received peptide treatment (Table 1), a single intravenous injection of active or mutant peptide (0.05 mg/kg) in normal saline (Baxter) was administered via the tail vein at 30 minuntes post-SCI in accordance with previous literature (Plummer et al., 2018).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!